Codexis
North America, California, United States, Redwood City
Description
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.
Investor Profile
Codexis has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Genetics, Health Care.
Stage Focus
- Series A (33%)
- Series B (33%)
- Series C (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Genetics
- Health Care
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
